We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Subcutaneous ICD Protects the Beating Heart

By HospiMedica International staff writers
Posted on 04 May 2016
Print article
Image: The EMBLEM S-ICD system (Photo courtesy of Boston Scientific).
Image: The EMBLEM S-ICD system (Photo courtesy of Boston Scientific).
A novel implantable cardioverter defibrillator (ICD) uses a subcutaneous electrode to analyze heart rhythm, in order to effectively protect patients from sudden cardiac arrest (SCA), while leaving the heart and vasculature untouched.

The EMBLEM S-ICD System provides a new solution to protect patients from SCA without touching the heart, avoiding potential complications associated with transvenous implantable defibrillators. While the EMBLEM S-ICD System utilizes a pulse generator--similar to those in a transvenous ICD--it differs in that it uses a subcutaneous electrode to analyze the heart rhythm, rather than individual beats to effectively sense, discriminate, and convert ventricular fibrillation (VF) and ventricular tachycardia (VT).

The EMBLEM S-ICD System also includes SMART Pass technology, which helps ensure patients receive therapy from the device only when necessary by enhancing a proprietary algorithm that identifies and classifies heart rhythm for effective arrhythmia treatment. A second feature, the atrial fibrillation (AF) monitor, is designed to help physicians make more informed treatment decisions. The EMBLEM S-ICD family is a product of Boston Scientific Corporation (Natick, MA, USA), and has received the European Community CE mark of approval.

In Europe, the EMBLEM magnetic resonance imaging (MRI) S-ICD System has been designated as an Image Ready MR-conditional device, and is labeled safe for use in a MRI setting. Patients receiving the EMBLEM MRI S-ICD System, as well as patients who previously were implanted with an EMBLEM S-ICD system are now able to undergo full-body MR scans safely in 1.5 Tesla environments, when conditions of use are met. Boston Scientific is actively pursuing U.S. Food and Drug Administration (FDA) approval of the systems.

“These approvals give reassurance to physicians and their patients that they have access to any future MR scan needs, and underscores the Boston Scientific commitment to gain MR-conditional labeling on high-voltage devices that are being implanted today,” said Kenneth Stein, MD, chief medical officer of rhythm management at Boston Scientific. “Further, the EMBLEM S-ICD System is a compelling treatment option for the majority of ICD-indicated patients that provides protection from cardiac arrest without invading the heart and blood vessels.”

Related Links:
Boston Scientific

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Physician Scale
Apex Digital

Print article

Channels

Surgical Techniques

view channel
Image: The Early Bird Bleed Monitoring System provides visual and audible indicators of the onset and progression of bleeding events (Photo courtesy of Saranas)

Novel Technology Monitors and Lowers Bleeding Complications in Patients Undergoing Heart Procedures

Bleeding complications at the femoral access site can significantly hamper recovery, affecting the success of procedures, patient satisfaction, and overall healthcare costs. It is crucial for surgeons... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.